Does education influence COVID-19 vaccination? A global view.

Dan Lupu, Ramona Tiganasu
Author Information
  1. Dan Lupu: "Alexandru Ioan Cuza" University of Iasi, Romania, Faculty of Economics and Business Administration, Romania.
  2. Ramona Tiganasu: "Alexandru Ioan Cuza" University of Iasi, Faculty of Law, Centre for European Studies, Romania.

Abstract

After the recent hard attempts felt on a global scale, notably in the health sector, the steady efforts of scientists have been materialized in maybe one of the most expected findings of the last decades, i.e. the launching of the COVID-19 vaccines. Although it is not our goal to plead for vaccination, as the decision in this regard is a matter of individual choice, we believe it is necessary and enlightening to analyze how one's educational status interferes with COVID-19 vaccination. There are discrepancies between world states vis-à-vis their well-being and their feedback to crises, and from the collection of features that can segregate the states in handling vaccination, in this paper, the spotlight is on education. We are referring to this topic because, generally, researches converge rather on the linkage between economic issues and COVID-19 vaccination, while education levels are less tackled in relation to this. To notice the weight of each type of education (primary, secondary, tertiary) in this process, we employ an assortment of statistical methods, for three clusters: 45 low-income countries (LICs), 72 middle-income countries (MICs) and 53 high-income countries (HICs). The estimates suggest that education counts in the COVID-19 vaccination, the tertiary one having the greatest meaning in accepting it. It is also illustrated that the imprint of education on vaccination fluctuates across the country groups scrutinized, with HICs recording the upper rates. The heterogeneity of COVID-19 vaccination-related behaviors should determine health authorities to treat this subject differently. To expand the COVID-19 vaccines uptake, they should be in an ongoing dialogue with all population categories and, remarkably, with those belonging to vulnerable communities, originated mostly in LICs. Education is imperative for vaccination, and it would ought to be on the schedule of any state, for being assimilated into health strategies and policies.

Keywords

References

  1. BMC Public Health. 2022 May 25;22(1):1044 [PMID: 35614426]
  2. Vaccine. 2023 Jan 27;41(5):1161-1168 [PMID: 36624011]
  3. Vaccine. 2023 Jan 9;41(2):496-503 [PMID: 36494253]
  4. Hum Vaccin Immunother. 2018;14(8):2058-2068 [PMID: 29580159]
  5. Heliyon. 2023 May;9(5):e15776 [PMID: 37153419]
  6. Vaccine. 2023 May 11;41(20):3151-3155 [PMID: 37045680]
  7. PLoS Negl Trop Dis. 2022 Jan 28;16(1):e0010103 [PMID: 35089917]
  8. Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621 [PMID: 33242386]
  9. Fam Med. 2000 May;32(5):338-41 [PMID: 10820676]
  10. J Epidemiol Community Health. 2020 Aug;74(8):620-623 [PMID: 32385126]
  11. Vaccines (Basel). 2021 Mar 21;9(3): [PMID: 33801136]
  12. Appl Health Econ Health Policy. 2023 Jul;21(4):603-614 [PMID: 37155007]
  13. Hum Vaccin Immunother. 2021 Jul 3;17(7):2279-2288 [PMID: 33522405]
  14. Hum Vaccin Immunother. 2021 Dec 2;17(12):5013-5015 [PMID: 34715003]
  15. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-8 [PMID: 34379568]
  16. Eur Child Adolesc Psychiatry. 2023 Mar;32(3):537-539 [PMID: 34550459]
  17. Public Health Pract (Oxf). 2023 Jun;5:100384 [PMID: 37038538]
  18. Health Policy Technol. 2023 Mar;12(1):100699 [PMID: 36415885]
  19. BMC Public Health. 2023 Jun 5;23(1):1073 [PMID: 37277743]
  20. Public Health. 2022 Sep;210:114-122 [PMID: 35963036]
  21. Int J Environ Res Public Health. 2022 Nov 09;19(22): [PMID: 36429444]
  22. J Afr Am Stud (New Brunsw). 2022;26(3):297-313 [PMID: 36247030]
  23. Prev Med. 2020 May;134:106063 [PMID: 32197975]
  24. Vaccine X. 2023 Apr;13:100272 [PMID: 36818493]
  25. J Health Commun. 2022 Jun 3;27(6):416-426 [PMID: 36069353]
  26. Nat Hum Behav. 2021 Apr;5(4):529-538 [PMID: 33686204]
  27. Health Psychol. 2023 Mar;42(3):205-212 [PMID: 36066859]
  28. Lancet Infect Dis. 2022 Sep;22(9):1293-1302 [PMID: 35753318]
  29. Hum Vaccin Immunother. 2022 Dec 31;18(1):2025733 [PMID: 35113775]
  30. J Hum Rights Soc Work. 2023 Apr 28;:1-7 [PMID: 37360668]
  31. Lancet Glob Health. 2023 Mar;11(3):e385-e413 [PMID: 36706770]
  32. Public Health Pract (Oxf). 2022 Dec;4:100309 [PMID: 36061136]
  33. Lancet Reg Health Eur. 2022 Jun;17:100381 [PMID: 35434685]
  34. Heliyon. 2022 Dec;8(12):e12300 [PMID: 36530926]
  35. Vaccine X. 2022 Dec;12:100234 [PMID: 36407819]
  36. Public Health. 2022 Dec;213:61-67 [PMID: 36371953]
  37. Nat Hum Behav. 2021 Jul;5(7):947-953 [PMID: 33972767]
  38. Vaccine X. 2021 Dec;9:100114 [PMID: 34518818]
  39. FASEB J. 2022 Jul;36(7):e22382 [PMID: 35657606]
  40. Health Place. 2023 Jan;79:102963 [PMID: 36592485]
  41. Heliyon. 2022 Sep 13;8(9):e10575 [PMID: 36120496]
  42. Hum Vaccin Immunother. 2021 Oct 3;17(10):3433-3440 [PMID: 34289316]
  43. Soc Sci Med. 2021 Mar;272:113638 [PMID: 33414032]
  44. Microbiol Spectr. 2023 Feb 14;11(1):e0424022 [PMID: 36695597]
  45. Public Health. 2021 Sep;198:200-207 [PMID: 34481275]
  46. Public Health. 2022 Aug;209:82-89 [PMID: 35870290]
  47. Infect Drug Resist. 2020 Oct 27;13:3817-3832 [PMID: 33149627]
  48. Patient Prefer Adherence. 2022 Aug 25;16:2321-2333 [PMID: 36046497]
  49. J Bioeth Inq. 2023 Mar;20(1):125-138 [PMID: 36630062]
  50. PLoS One. 2022 Nov 9;17(11):e0277435 [PMID: 36350924]
  51. Heliyon. 2022 Jan;8(1):e08699 [PMID: 34981036]
  52. Vaccine. 2021 Sep 24;39(40):6004-6012 [PMID: 33160755]
  53. Health Commun. 2022 Nov;37(12):1457-1464 [PMID: 35135397]
  54. Diabetes Res Clin Pract. 2016 Oct;120:117-23 [PMID: 27541821]
  55. Hum Vaccin Immunother. 2022 Nov 30;18(5):2085469 [PMID: 35687802]
  56. Sci Rep. 2022 Oct 27;12(1):18067 [PMID: 36302883]
  57. Vaccine. 2020 Jun 15;38(29):4536-4541 [PMID: 32448621]
  58. Discov Soc Sci Health. 2022;2(1):20 [PMID: 36340573]
  59. J Community Health. 2022 Aug;47(4):666-673 [PMID: 35513757]
  60. Hum Vaccin Immunother. 2022 Nov 30;18(5):2064685 [PMID: 35580319]
  61. Sci Rep. 2022 Oct 19;12(1):17474 [PMID: 36261454]
  62. Soc Sci Med. 2022 Sep;309:115248 [PMID: 35969977]
  63. J Evid Based Med. 2022 Sep;15(3):245-262 [PMID: 36000160]
  64. Hum Vaccin Immunother. 2022 Dec 31;18(1):2013694 [PMID: 35172676]
  65. Environ Res. 2022 Oct;213:113566 [PMID: 35660409]
  66. Soc Sci Med. 2023 Mar;321:115759 [PMID: 36774703]
  67. Vaccines (Basel). 2022 Nov 15;10(11): [PMID: 36423028]
  68. J Health Econ. 2021 Dec;80:102531 [PMID: 34607120]
  69. Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107 [PMID: 35044620]

Word Cloud

Created with Highcharts 10.0.0educationCOVID-19vaccinationhealthcountriesLICsHICsglobalonevaccinesstatestertiaryMICsstrategiesrecenthardattemptsfeltscalenotablysectorsteadyeffortsscientistsmaterializedmaybeexpectedfindingslastdecadesielaunchingAlthoughgoalpleaddecisionregardmatterindividualchoicebelievenecessaryenlighteninganalyzeone'seducationalstatusinterferesdiscrepanciesworldvis-à-viswell-beingfeedbackcrisescollectionfeaturescansegregatehandlingpaperspotlightreferringtopicgenerallyresearchesconvergeratherlinkageeconomicissueslevelslesstackledrelationnoticeweighttypeprimarysecondaryprocessemployassortmentstatisticalmethodsthreeclusters:45low-income72middle-income53high-incomeestimatessuggestcountsgreatestmeaningacceptingalsoillustratedimprintfluctuatesacrosscountrygroupsscrutinizedrecordingupperratesheterogeneityvaccination-relatedbehaviorsdetermineauthoritiestreatsubjectdifferentlyexpanduptakeongoingdialoguepopulationcategoriesremarkablybelongingvulnerablecommunitiesoriginatedmostlyEducationimperativeschedulestateassimilatedpoliciesinfluencevaccination?viewHealthPrimarySecondaryTertiary

Similar Articles

Cited By (4)